| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $396.1M | +14.2% |
| Cost of Revenue | $153.2M | +9.4% |
| Gross Profit | $242.9M | +17.5% |
| R&D Expense | $102.6M | +23.2% |
| SG&A Expense | $78.9M | +3.5% |
| Operating Income | -$187.5M | -94.9% |
| Interest Expense | $15.1M | +9855.9% |
| Pre-tax Income | -$187.4M | -91.2% |
| Income Tax | $10.6M | +641.6% |
| Net Income | -$198.0M | -99.1% |
| EPS (Basic) | -$1.51 | -88.8% |
| EPS (Diluted) | -$1.51 | -88.8% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $203.2M | +79.1% |
| Accounts Receivable | $91.7M | +11.5% |
| Current Assets | $518.6M | +57.9% |
| Total Assets | $668.6M | +51.5% |
| Current Liabilities | $311.6M | +42.1% |
| Long-term Debt | $210.4M | — |
| Total Liabilities | $571.4M | +111.1% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.6M | -210.5% |
| Capital Expenditures | $10.6M | +21.2% |
| Investing Cash Flow | -$131.1M | -552.1% |
| Financing Cash Flow | $241.9M | +1026.1% |
| Free Cash Flow | -$31.3M | -415.6% |
| Stockholders' Equity |
| $97.2M |
| -43.1% |